The expression of the recently identified dermokine (Dmkn) gene leads to four families of proteins with as yet unknown functions. The secreted a, b and c isoforms share an epidermis-restricted expression pattern, whereas the d isoform is intracellular and ubiquitous. To get an insight into Dmknd function, we performed yeast two-hybrid screening and identified the small GTPases Rab5 as partners for Dmknd. The Rab5 proteins are known to regulate membrane docking and fusion in the early endocytic pathway. GST pull-down assays confirmed the direct interaction between Rab5 and Dmknd. Transient expression of Dmknd in HeLa cells led to the formation of punctate structures colocalized with endogenous Rab5 and clathrin, indicating Dmknd involvement in the early steps of endocytosis. Dmknd indeed colocalized with transferrin at early stages of endocytosis, but did not modulate its endocytosis or recycling kinetics. We also showed that Dmknd was able to bind both inactive (GDP-bound) and active (GTP-bound) forms of Rab5 in vitro but preferentially targeted GDP-bound form in HeLa cells. Interestingly, Dmknd expression rescued the Rab5S34N-mediated inhibition of endosome fusion. Moreover, Dmknd caused the enlargement of vesicles positive for Rab5 by promoting GTP loading onto the small GTPase. Together our data reveal that Dmknd activates Rab5 function and thus is involved in the early endosomal trafficking.
Introduction
The recent identification of the Dermokine (Dmkn) gene came from different studies carried out to identify new genes specifically expressed during the late stage of epidermis differentiation [1, 2, 3, 4, 5] . Mapped to human chromosome 19q13.1, Dmkn spans 25 exons. Its expression leads to four groups of transcripts according to three different transcriptional start sites, two transcriptional termination sites, and several alternative coding exons [3] . The corresponding isoforms were named a, b, c and d. The d transcripts, spanning from exon 6 to exon 25, are radically different from the a, b and c transcripts [3] . First, they show a very broad pattern of expression, including numerous tissues and organs [3, 6, 7, 8] , whereas a, b and c mRNAs expression is mainly restricted to epidermis. Second, unlike a-, b-and c-groups, d mRNAs do not encode a putative signal peptide and are predicted to produce cytosolic proteins. This was confirmed by the expression of recombinant Dmknd in transfected 293/EBNA cells [3] . Finally, the d family of transcripts is represented by a surprisingly broad number of members. We cloned up to 9 different cDNAs from human epidermis, potentially encoding 6 different Dmknd proteins [3] .
Rab proteins make up the largest subfamily of small GTPases that play central roles in intracellular membrane trafficking. So far, in humans, the Rab family has been shown to have more than 60 proteins scattered around distinct intracellular compartments, where they regulate vesicle budding, transport and fusion [9, 10] . Rab proteins cycle between an active (GTPbound) and an inactive (GDP-bound) state. The nucleotide switch leads to a Rab conformational change which determines the interaction with specific regulators and effectors that are located both on membranes and in the cytosol [11] . For example, the GDP/GTP exchange factors (GEFs) catalyze the conversion from the GDP-to GTP-bound state, whereas GTPase-activating proteins (GAPs) catalyze GTP hydrolysis [12] . Among the Rab family of proteins, Rab5 is a key player in the early endocytic pathway. It regulates clathrin-coated vesiclemediated transport from the plasma membrane to the early endosomes as well as homotypic early endosome fusion. Moreover, it has also been implicated in endosome motility along microtubules [13] and actin filaments [14] and also in growth factor signalling [15] . The three Rab5 paralogues Rab5a, b and c [16] , encode isoforms showing distinct tissue distributions [17] . At least 20 cytosolic proteins specifically interact with active Rab5, highlighting the complexity of the downstream regulation by this GTPase [18] .
The Dmknd share no sequence similarity with any known protein. In order to elucidate its role we thus performed yeast twohybrid screening and identified the Rab5 proteins as partners. By GST pull-down experiments and confocal microscopy analysis of transiently transfected HeLa cells, we further characterized the involvement of Dmknd in the early endosomal trafficking.
Materials and Methods

Yeast two-hybrid screening
The yeast reporter strain AH109 was sequentially transformed with pGBKT7-Dmknd5 and a cDNA library (Matchmaker human keratinocyte library in pGAD10, Clontech) following the instructions of the Matchmaker Gal4 two-hybrid system (Clontech). The double transformants were plated on selective medium lacking tryptophan, leucine and histidine and grown at 30uC for 5 days. Positive colonies were then picked, plated on selective medium lacking tryptophan, leucine, histidine and adenine, and tested for b-galactosidase activity using a replica plate assay. About 2.5 million library clones were screened. Library plasmids from positive colonies were isolated using Fast Prep (Thermo Scientific), rescued into E. coli DH5a and sequenced.
Antibodies
Primary antibodies were: polyclonal anti-Rab5b and anti-Rab7 (Santa Cruz Biotechnology), monoclonal anti-Rab11, anti-LAMP1 and anti-EEA1 (BD Biosciences), monoclonal anti-clathrin (Abcam), monoclonal anti-GST (Cell Signaling Technology) and anti-GFP (Novus Biologicals). Alexa-Fluor-555 secondary antibodies were obtained from Invitrogen.
Cell culture and transfection
HeLa cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) plus GlutaMAX TM supplemented with 10% heat-inactivated foetal bovine serum, 50 U/ml penicillin and 50 mg/ml streptomycin (Invitrogen) at 37uC in 5% CO 2 . HeLa cells were transfected with plasmid constructs using JetPEI reagent (Polyplus Transfection), according to the manufacturer's instructions.
Plasmid constructs
All cDNA clones used in this study were obtained by polymerase chain reaction (PCR) with specific primers. The DNA sequence of the insert as well as the flanking regions in each cDNA clone was verified by sequencing.
Yeast two-hybrid constructs. Dmknd5 cDNA was generated by PCR with the previously made pCEP4 construct as template [3] , and cloned into the pCR2.1TOPO vector (Invitrogen). cDNAs of Dmknd5, Dmknd5-Nt (corresponding to exons 13 to 19 of Dmknd5), and Dmknd5-Ct (corresponding to exons 20 to 23 of Dmknd5), were subcloned into the pGBKT7 vector (Clontech). Rab5a cDNA was PCR amplified using the pCMV-SPORT6-Rab5a (purchased from RZPD) as template and cloned into the pGADT7 plasmid (Clontech).
Constructs for in vitro binding assays. Dmknd5, Dmknd5-Nt and Dmknd5-Ct cDNAs were cloned into the pGEX-6P-1 expression vector (Amersham Biosciences). Wildtype Rab5b (wt) cDNA was amplified by PCR from the pGAD10 construct rescued from yeast two-hybrid screening, and cloned into pCR2.1TOPO. The previously described mutants Rab5S34N and Rab5Q79L [19] were generated by site-directed PCR mutagenesis using Rab5bwt cDNA as template and specific primers harbouring the mutation concerned. Each Rab5b form was subcloned into the pGEX-6P-1 plasmid. The previously described ''Rab5 binding domain'' (R5BD) comprising the last 73 amino acids of rabaptin-5 [20] was obtained by RT-PCR from total HeLa cells mRNA and cloned into the pGEX-6P-1 plasmid.
Constructs for the localization studies. Dmknd5 and Rab5b constructs were cloned into the pEGFP-C1 and pDsRed1-C1 vectors (Clontech) respectively.
Recombinant proteins
The pGEX-6P-1 vectors were transformed into E. coli BL21-CodonPlus competent cells (Stratagene) and protein expression was induced with 1 mM isopropyl thio-b-D-galactoside (IPTG) for 2 hours at 37uC. Recombinant GST proteins were then extracted from bacteria cells and purified on a Glutathione Sepharose 4 Fast Flow column (Amersham Biosciences) according to the manufacturer's instructions. GST-Rab5bwt recombinant protein was further treated with PreScission Protease (GE Healthcare) to remove the GST moiety following the manufacturer's recommendations.
Immunoblotting
Proteins separated by SDS-PAGE were transferred to a Hybond-C extra membrane (GE Healthcare) and probed overnight at 4uC with primary antibodies. Bound antibodies were detected with horseradish peroxidase-conjugated secondary antibodies and developed using the Lumi-Light kit (Roche Applied Science). To determine relative protein amounts, three representative exposures for each sample were quantitated by densitometry analysis using the ImageJ free software.
HeLa cell protein extract
HeLa cells were harvested 36 hours after transfection in lysis buffer (25 mM Hepes-NaOH pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 1% NP40, 10% glycerol, 1 mM DTT, protease inhibitors). Extracts were incubated for 5 minutes on ice and clarified by centrifugation (10,0006g, 1 minute, 4uC). The supernatants were recovered and used for further pull-down assays.
GST pull-down assays 20 mg of glutathione sepharose (GS) beads were coated with 30 mg of GST-Dmknd5 or GST alone for 1 hour at 4uC. After washing and equilibration, Hela cell protein extract or 10 mg of Rab5b recombinant protein were incubated for 1 hour at 4uC with coated beads. Interacting complexes were eluted with 10 mM Gluthation pH 8 and subjected to immunoblotting. In some cases, cleaved Rab5bwt recombinant protein was preloaded with 500 mM of GppNHp, a non-hydrolysable analogue of GTP or 500 mM of GDP (Jena Biosciences), overnight at 4uC, in the presence of 10 mM EDTA and 0.3% b-mercaptoethanol. The nucleotide binding reaction was stopped by adding 10 mM MgCl 2 . GppNHp-bound Rab5bwt and GDP-bound Rab5bwt were used for further pull-down assays.
GTP-loaded Rab5 pull-down assay
The GST-R5BD pull-down assay was performed as previously described [21] . Briefly, 80 mg of GS beads were coated with 100 mg of GST-R5BD. Beads were then incubated with fresh transfected HeLa cell protein extract for 1 hour at 4uC. Eluted interacting complexes were subjected to immunoblotting.
Immunofluorescence
Hela cells were grown on glass coverslips for 24 hours and subjected or not to transient transfection. After 36 hours, the cells were fixed with methanol at 220uC for 2 minutes. For indirect immunofluorescence experiments, cells were immunostained with primary antibodies for 1 hour at 37uC. The respective AlexaFluor conjugated secondary antibodies were then incubated for 1 hour at room temperature. After extensive washing with PBS, the coverslips were mounted in Mowiol (Sigma-Aldrich) on glass slides and imaged on a Carl Zeiss confocal microscope LSM710. Final images were analysed using the Zen software (Carl Zeiss).
Transferrin internalization assay
To deplete endogenous transferrin, HeLa cells transiently expressing GFP-Dmknd5 or not were serum-starved for 2 hours at 37uC in internalization medium (IM) consisting of DMEM with 20 mM Hepes-NaOH (pH 7.4) and 2 mg/ml BSA added. Cells were then placed on ice, and incubated for 30 minutes at 4uC in IM containing 50 mg/ml Alexa Fluor-555 labelled transferrin (Invitrogen). After washing with ice-cold PBS, prewarmed IM was added to the cells to allow internalization of transferrin, followed by incubation at 37uC for the times indicated. The reaction was stopped by putting the cells back on ice and washing with ice-cold PBS. Cells were then fixed and processed for confocal microscopy analysis as described for the immunofluorescence experiments.
Flow cytometry
Internalization and recycling of transferrin were quantified by fluorescence-activated cell sorter (FACS), in HeLa cells transiently expressing GFP-Dmknd5 or GFP alone. For these experiments, we used Alexa Fluor-647 labelled transferrin (Invitrogen) at the final concentration of 10 mg/ml in IM.
Internalization assay was performed as described above except that, after stopping the reaction, the non-internalized transferrin was removed by washing with ice-cold 0.2 M acetic acid (pH 2.8) containing 0.5 M NaCl. Cells were then washed with ice-cold PBS and detached with ice-cold PBS containing 5 mM EDTA. After washing with ice-cold PBS cells were resuspended in FACS buffer (2% BSA in PBS). Alexa Fluor-647 labelled transferrin uptake was measured by flow cytometry and the percentage of transferrin that was internalized at each time-point was calculated by subtracting background (fluorescence of cells subjected to acid wash without allowing internalization) and then normalized by the total amount of transferrin prebound at +4uC.
For recycling experiments, cells depleted of endogenous transferrin were incubated for 15 minutes at 37uC with prewarmed Alexa Fluor-647 labelled transferrin in IM. Cells were then placed on ice and washed with ice-cold PBS. Then, prewarmed IM was added followed by incubation at 37uC for the times indicated. Cells were then placed on ice, washed with ice-cold-PBS, and detached with trypsin. Harvested cells were washed in ice-cold-PBS and resuspended in FACS buffer. The amount of the fluorescent transferrin remained (non-released) in cells was measured by flow cytometry and expressed as the percentage of the initial intracellular transferrin amount detected in cells (100%, time 0 of recycling), in each experimental condition. Flow cytometry and data collection were performed on a FACSCalibur cell sorter (BD Biosciences). Data analysis was done using the WinMDI free software.
Results
The Dmknd isoform family
From the nine Dmknd variants we previously cloned from human epidermis [3] , we could deduce the sequence of 6 hypothetical proteins. All of them share a 123-amino-acid-length minimal sequence, and could be distinguished by 3 putative first methionine and additional sequences encoded by the alternative exons ( Figure 1 and [3] ). Unlike the other Dmkn groups of transcripts, Dmknd mRNAs were shown to be ubiquitously expressed [3] . The following experiments presented in this paper which were carried out in order to characterize Dmknd function, were performed with the Dmknd5 isoform. The Dmknd5 protein displays the minimal sequence present in all the Dmknd plus the amino acids encoded by the alternative exon 20.
Identification of Rab5 as a binding partner for Dmknd5
The peptide sequences of the Dmknd isoforms did not reveal any similarity with known functional domains. In order to gain an insight into Dmknd function, we looked for potential partners using yeast two-hybrid analysis. We screened a human keratinocyte cDNA library with Dmknd5 as a bait and obtained 5 clones growing on selective medium and positive for the b-galactosidase reporter gene assay. Four of them corresponded to full-length Rab5c and one to full-length Rab5b (Figure 2A ). The small GTPase Rab5 having three isoforms that share 90% of sequence identity [16] , we used the yeast two-hybrid system and found that the third isoform, Rab5a, was also able to interact with Dmknd5 ( Figure 2A ). All further experiments were carried out using the Rab5b isoform. In order to confirm the interaction between Dmknd5 and Rab5, we performed GST pull-down assays using bacterially expressed recombinant Dmknd5. GST-Dmknd5 was able to retain Rab5, either present in HeLa protein extract or produced as recombinant ( Figure 2B ). These data indicated that Dmknd5 interacts with the endogenous Rab5 and confirmed that the interaction is direct. As we could not obtain Dmknd specific antibody, we further analysed the localization of the endogenous Rab5 and the Dmknd5 by confocal microscopy performed on HeLa cells expressing a GFP-tagged Dmknd5. Rab5 was distributed throughout the cell body, with accumulation at the nuclear periphery ( Figure 2C , middle panel) as previously described [22] . GFP-Dmknd5 was detected as diffuse in the cytosol as well as concentrated in puncta localized in the perinuclear region ( Figure 2C , left panel) where it partially colocalized with endogenous Rab5 (Figure 2C, arrowheads) . The size of these structures, 0.5 to 1 mm, is typical of endosomal vesicles [19] . The expression of GFP alone only induced a diffuse cytosolic green labelling (data not shown), proving that the vesicle staining was related to Dmknd5 expression.
The domain of Dmknd5 responsible for the interaction with Rab5 resides in the N-terminus region of the protein
To specify the domain of Dmknd5 involved in the interaction with Rab5, we constructed cDNAs encoding the N-terminus (Nt) or the C-terminus (Ct) of the protein, encompassing amino-acid residues 1 to 76 and 77 to 137, respectively. These constructs were assayed for interaction with Rab5, first by using the yeast twohybrid system. As shown in figure 3A , only the clones expressing Dmknd5-Nt grew on selective medium and expressed an active LacZ reporter gene. Thus, Dmknd5 interacts with the small GTPase via its first 76 amino-acid residues. We then investigated the subcellular localization of both Dmknd5 regions by confocal microscopy analysis of HeLa cells co-transfected with GFPDmknd5-Nt or -Ct and DsRed-Rab5wt ( Figure 3B ). We found that GFP-Dmknd5-Nt was localized in large endosome-like structures that were also positive for DsRed-Rab5wt, whereas GFP-Dmknd5-Ct showed a diffuse cytosolic pattern of expression and never colocalized with the DsRed-Rab5wt-positive large endosomes. These results are consistent with the yeast two-hybrid assay and suggest that the vesicular location of Dmknd5 is associated with the interaction of its N-terminus with Rab5.
Dmknd5 appears to be involved early in the endocytic pathway
To further characterize the nature of GFP-Dmknd5 positive structures, we analysed its co-localization in HeLa cells with several well-characterized organelle markers of the endocytic pathway ( Figure 4) . We first checked that transient expression of GFP-Dmknd5 had no impact on the subcellular localization of these proteins. We next found that GFP-Dmknd5 colocalized with clathrin on vesicles ( Figure 4A, arrowheads) . Moreover, GFPDmknd5 never colocalized with the Rab5 effector EEA1, suggesting that the GFP-Dmknd5 vesicles positive for Rab5 are distinct from early endosomes ( Figure 4B ). We also tested the late endosomal marker Rab7, the lysosomal protein LAMP1 and the recycling endosomal Rab11 and never noted any colocalization with GFP-Dmknd5 ( Figure 4C-E) . Dmknd5 could thus play its role in the endocytic pathway, as early as the formation of clathrincoated vesicles.
In order to confirm these results, we performed pulse-chase experiments of Alexa-labelled transferrin in HeLa cells untransfected or transiently expressing the GFP-Dmknd5 (Figure 5A ). At the beginning of the chase (0 min), transferrin labelling was detected on the plasma membrane. Fluorescent transferrin was subsequently internalized and accumulated in big perinuclear puncta formed by the transient expression of GFP-Dmknd5 in the cytoplasm ( Figure 5A, 4 min, arrowheads) . The staining of the membrane was no longer visible. After ten minutes of chase, colocalization of transferrin and GFP-Dmknd5 strongly diminished ( Figure 5A , 10 min, arrowheads), and was no longer noticeable after 15 minutes of uptake. We next investigated whether the colocalization of GFP-Dmknd5 with transferrin at early stages of endocytosis had an impact on the kinetic of transferrin uptake or recycling by fluorescence-activated cell sorter. No accelerated or delayed kinetics of internalization or recycling of transferrin was observed in HeLa cells expressing GFP-Dmknd5 in comparison to HeLa cells expressing GFP alone ( Figure 5B, C) . Overall, these results confirm that Dmknd5 plays its role upstream of early endosomes, probably during the clathrin-coated vesicle formation and/or transport to the sorting endosome, but does not modulate the kinetics of endocytosis or recycling of transferrin.
Dmknd5 interacts in vitro with both inactive and active forms of Rab5, but preferentially colocalizes with inactive Rab5 in vivo
Protein interaction with Rab5 is modulated according to the nucleotide status of the small GTPase. In order to determine whether Dmknd5 interacts preferentially with the active or the inactive form of Rab5, we performed GST pull-down assays. Recombinant Rab5 was subjected to an exchange reaction to load it with either GppNHp or GDP and test its interaction with GSTDmknd5 immobilized on glutathione-sepharose beads. Both GppNHp and GDP-bound Rab5 were retained by GST-Dmknd5 ( Figure 6A ). We then analysed the in vivo colocalization of Dmknd5 with the constitutively active or inactive forms of Rab5. For this purpose, HeLa cells were co-transfected with GFPDmknd5 and DsRed-Rab5Q79L, or DsRed-Rab5S34N. Expres- sion of the constitutively active DsRed-Rab5Q79L induced the formation of giant early endosomes as previously described [19] . These structures appeared negative for GFP-Dmknd5 which localized to smaller vesicles ( Figure 6B, upper panel) . In contrast, GFP-Dmknd5 colocalized with DsRed-Rab5S34N to a large extent ( Figure 6B, middle panel) . Interestingly, the forced expression of Dmknd5 seemed to modify the morphology and the localization of the structures positive for the dominant negative Rab5 mutant. HeLa cells expressing GFP and DsRed-Rab5S34N formed typical tubulo-vesicular structures consistent with the inability of the mutant to promote membrane fusion [19] (Figure 6B, lower panel) . In contrast, GFP-Dmknd5 and DsRed-Rab5S34N colocalized into big endosome-like vesicles (1-1.5 mm) scattered around the cytoplasm. Hence, Dmknd5 is able to interact with both the active and the inactive forms of Rab5 in vitro, but preferentially localizes with the inactive mutant of Rab5 in vivo.
Dmknd5 modifies the balance between inactive/active Rab5 in HeLa cells
Interestingly, we saw that, when GFP-Dmknd5 was expressed in addition to DsRed-Rab5wt, it induced the enlargement of the DsRed-Rab5wt positive structures ( Figure 7A ). The diameter of these vesicles increased from 1-1.5 mm when DsRed-Rab5wt was coexpressed with GFP alone ( Figure 7A, lower panel) , to 2-3 mm when it was coexpressed with GFP-Dmknd5 ( Figure 7A upper  panel) . The large to giant vesicles induced by the transient expression of GFP-Dmknd5 together with DsRed-Rab5wt are reminiscent of the giant endosomes caused by the constitutively active form Rab5Q79L [19] . This suggests that Dmknd5 has an impact on the switch between the inactive (GDP-bound) and the active (GTP-bound) state of Rab5. To clarify this issue, we performed a GST pull-down assay based on the ability of the Rab5 binding domain (R5BD) of Rabaptin5, a Rab5 effector, to specifically link GTP-bound Rab5 [20, 23] . We produced GST-R5BD recombinant protein and used it to pull down Rab5-GTP in HeLa protein extract. HeLa cells were transfected with DsRed- Rab5wt and either GFP, GFP-Dmknd5, GFP-Dmknd5-Nt or GFP-Dmknd5-Ct. We checked that all these GFP-tagged proteins were efficiently expressed in transfected HeLa cells, as shown in Figure 7B (bottom panel). Using an anti-Rab5 antibody, we confirmed the presence of the DsRed-Rab5wt in HeLa protein extracts ( Figure 7B, middle panel) . We also detected, with the same antibody, the DsRed-Rab5-GTP retained by the R5BD-GST beads ( Figure 7B, upper panel) . After quantification by densitometry, we found significantly increased levels of active DsRed-Rab5wt among cells expressing GFP-Dmknd5 (,2.5 fold) and, to a lesser extent, in cells expressing GFP-Dmknd5-Nt (,1.5 fold) ( Figure 7C ). This is consistent with our previous observation that GFP-Dmknd5-Nt coexpressed with DsRed-Rab5wt did not induce the formation of giant vesicles (see Figure 3B ). In contrast, the C-terminal domain of Dmknd5 had no effect on DsRed-Rab5wt GTP level ( Figure 7B, C) . We can thus conclude that Dmknd5 is able to modulate Rab5 activity by promoting its GTP loading. Moreover, the N-terminal region of Dmknd5 does not seem to be fully functional, although it is able to interact with Rab5.
Discussion
In this work, we describe for the first time the function of the ubiquitous Dmkn isoform, Dmknd. By yeast two-hybrid and GST pull-down assays, we identified the small GTPase Rab5 as partner for Dmknd5.
We observed that Dmknd5 expression in HeLa cells modified some vesicle features. Dmknd5 is sufficient to relocalize the Rab5S34N dominant negative mutant to large vesicular structures, scattered around the cytosol. The expression of Dmknd5 could provoke endosome fusion in spite of the inhibitory effect of Rab5S34N. Such a rescue from Rab5S34N-mediated inhibition of endosome fusion has been described in the case of BHK cells transiently expressing the Rab5GEF Rabex5 [23] . Another feature of Dmknd5 is its ability to enlarge the vesicles induced by Rab5wt expression in HeLa cells, from 1-1.5 mm to more than 2 mm. This vesicle size is reminiscent of that observed when the Rab5-GTP mutant is expressed in HeLa cells [19] . These data suggest that Dmknd5 is able to promote early endosome fusion in vivo. Finally, we showed that Dmknd5 activated Rab5 in vivo, by promoting GTP loading onto the small GTPase. This result is consistent with the observed Dmknd5 impact on the morphology of Rab5 positive vesicles, and with Dmknd5 preferential targeting of the GDPbound Rab5 in vivo. Altogether, we found that Dmknd5 activated Rab5 function and thus was involved in early endosome dynamics.
The vesicles induced by Dmknd5 expression in HeLa cells colocalized only partially with Rab5. We thus investigated other known organelle markers in order to identify these Dmknd5 structures. We found colocalization only with clathrin, which is present on plasma membrane and clathrin-coated vesicles. The Dmknd5-positive vesicles never contained the early endosomal marker EEA1. These results were supported by the analysis of fluorescently labelled transferrin endocytosis. Transferrin was present in the same structures as Dmknd5, from 0 to 10 minutes of chase, which corresponds to the transport of transferrin from the plasma membrane to the early endosome. Colocalization was reduced after 10 minutes of uptake, a time reported to match the association of Rab5 with EEA1 positive endosomes [24] . Finally, colocalization was no longer visible 15 minutes after the beginning of the chase, a time corresponding to transferrin transfer into structures positive for Rab5 and Rab11 [25] . Therefore, Dmknd5 positive vesicles seem to transport transferrin from the plasma membrane to the sorting endosomes. However, we did not find any difference in the kinetics of the transferrin uptake or recycling between HeLa cells expressing GFP-Dmknd5 or not. We also investigated the specificity of Dmknd5 binding towards Rab5 nucleotide state. In vitro, we found that it could bind to either the active GTP-bound or the inactive GDP-bound form of Rab5. Similar biochemical properties have been reported in the case of ALS2, Varp or the RIN family [26, 27, 28, 29, 30] , all these proteins being identified as Rab5GEFs.
We identified the three Rab5 isoforms as partners for the Dmknd5. Currently, few data comparing these three proteins are available. In a large scale analysis of Rab protein distribution, Gurkan et al. found that, despite their high homology, Rab5a, b and c exhibited distinct tissue distribution [17] . Moreover, although the three isoforms play their major role in the early endocytic pathway [16] , they could be specifically regulated [31, 32] and differently involved in some processes [33, 34] . Their specificity of function may also reside in particular affinity with some partners, like GEF. It has recently been shown that Rin1 and Gapex-5, two Rab5 GEFs, could bind to either a single Rab or indifferently the three isoforms, respectively [15] . Dmknd5, like Gapex-5, showed no significant specificity towards isoforms.
Overall, these in vivo and in vitro experimental results strongly suggest that Dmknd5 acts like a GEF for Rab5. However, its amino-acid sequence lacks the well characterized VPS9 domain which is common to all Rab5 GEFs and required for the nucleotide exchange reaction [35] . Such properties have recently been described for another Rab5 partner, the caveolin-1 [36] . The authors hypothesized that caveolin-1 may recruit Rab5-GEF or promote its function onto Rab5, by direct binding. Dmknd5 might have the same properties.
Our yeast two-hybrid screening did not allow us to identify a molecular partner for Dmknd5 other than Rab5. However, this hypothesis is not excluded. Dmknd5 binds to Rab5 via its N-terminal domain but coexpression of GFP-Dmknd5-Nt and DsRed-Rab5wt in HeLa cells did not lead to formation of giant structures such as we observed when the full length GFP-Dmknd5 was expressed instead of the truncated protein. Consistent results were found with the R5BD pull-down assay, showing that Rab5 activation by Dmknd5 is reduced when only the N-terminal domain of the protein is expressed. Thus, the N-terminal part of Dmknd5 is necessary but not sufficient for full function on Rab5 activation. Consequently, Dmknd5 may interact, via its C-terminal domain, with another partner accounting for its modulation of Rab5 activation. Such an interaction may also be consistent with the vesicular location of Dmknd5, which is not always correlated with the Rab5 one.
In conclusion, we found that Dmknd5 is a new actor of the early endocytic pathway. Its direct interaction with Rab5 leads to activation of the small GTPase. We also showed that Dmknd5 is involved in endocytosis of transferrin. Further studies will help to determine which molecular mechanisms and other potential partners are involved in this process. Eche and F. L'Faqihi-Olive from the flow cytometry facility. We wish to acknowledge M. Simon and C. Leprince for critically reviewing the manuscript.
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